Cornerstone Management’s Pfizer PFE Stock Holding History

Cornerstone Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,728	Closed	-$70.5K	–	192
2023 Q1	$70.5K	Hold	1,728	–	–	0.02%	76
2022 Q4	$88.5K	Hold	1,728	–	–	0.02%	66
2022 Q3	$75.6K	Hold	1,728	–	–	0.02%	70
2022 Q2	$90.6K	Hold	1,728	–	–	0.02%	70
2022 Q1	$89.5K	Hold	1,728	–	–	0.02%	73
2021 Q4	$102K	Buy	+1,728	New	+$85.6K	0.03%	68
2016 Q4	–	Sell	-11,624	Closed	-$374K	–	42
2016 Q3	$374K	Sell	11,624 -289	-2%	-$9.66K	0.22%	33
2016 Q2	$398K	Hold	11,913	–	–	0.24%	32
2016 Q1	$335K	Sell	11,913 -656	-5%	-$18.7K	0.21%	34
2015 Q4	$385K	Buy	12,569 +932	+8%	+$29.3K	0.25%	32
2015 Q3	$347K	Buy	11,637 +527	+5%	+$16.9K	0.26%	33
2015 Q2	$353K	Sell	11,110 -214	-2%	-$6.97K	0.25%	34
2015 Q1	$374K	Sell	11,324 -214	-2%	-$6.8K	0.28%	34
2014 Q4	$341K	Buy	+11,538	New	+$331K	0.27%	35

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Management's PFE Position: Q2 2023 in Review

Cornerstone Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 1,728 shares — an estimated $70.5K sold.

Cornerstone Management first reported a position in PFE in Q4 2014 and held it in 14 quarters. The position peaked at $398K in Q2 2016. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Cornerstone Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Cornerstone Management sold 1,728 Pfizer shares in Q2 2023, an estimated $70.5K.
Cornerstone Management first reported a position in Pfizer in Q4 2014 and held it in 14 quarters.
Cornerstone Management's Pfizer position peaked at $398K in Q2 2016.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Cornerstone Management's 13F filing for Q2 2023, filed 10 Aug 2023.